Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Measuring Self-Reported Cancer-Related Cognitive Impairment: Recommendations From the Cancer Neuroscience Initiative Working Group
Ashley M. Henneghan, Kathleen Van Dyk, Tara Kaufmann, et al.
JNCI Journal of the National Cancer Institute (2021) Vol. 113, Iss. 12, pp. 1625-1633
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Brain tumor detection and classification using machine learning: a comprehensive survey
Javeria Amin, Muhammad Sharif, Anandakumar Haldorai, et al.
Complex & Intelligent Systems (2021) Vol. 8, Iss. 4, pp. 3161-3183
Open Access | Times Cited: 270
Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
Maryam B. Lustberg, Nicole M. Kuderer, Aakash Desai, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 527-542
Open Access | Times Cited: 106
The MASCC COG-IMPACT: An unmet needs assessment for cancer-related cognitive impairment impact developed by the Multinational Association of Supportive Care in Cancer
Darren Haywood, Alexandre Chan, Raymond J. Chan, et al.
Supportive Care in Cancer (2025) Vol. 33, Iss. 2
Open Access | Times Cited: 2
Prevalence and assessment tools of cancer-related cognitive impairment in lung cancer survivors: a systematic review and proportional meta-analysis
Mu‐Hsing Ho, Tsz Wei So, Chun Lun Fan, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 4
Open Access | Times Cited: 9
Anxiety, depression, and concentration in cancer survivors: National Health and Nutrition Examination Survey results
Joanna E. Fardell, Chase Irwin, Janette Vardy, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 5
Open Access | Times Cited: 18
Construction and validation of a risk-prediction model for chemotherapy-related cognitive impairment in patients with breast cancer
Yu Liu, Ruolin Li, Lü Chen, et al.
Journal of Cancer Survivorship (2024)
Closed Access | Times Cited: 6
Cancer-related cognitive impairment as a key contributor to psychopathology in cancer survivors: implications for prevention, treatment and supportive care
Darren Haywood, Melissa C. Henry, Evan Dauer, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 7
Open Access | Times Cited: 6
Relationship between cytokines and brain-derived neurotrophic factor (BDNF) in trajectories of cancer-related cognitive impairment
Ning Yi Yap, Yi Long Toh, Chia Jie Tan, et al.
Cytokine (2021) Vol. 144, pp. 155556-155556
Open Access | Times Cited: 37
Circadian disruption and cancer- and treatment-related symptoms
Ali Amidi, Lisa M. Wu
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 25
Protocol for the Development and Initial Validation of the COG-IMPACT Tool: A Purpose-Built Unmet Needs Assessment for Cancer-Related Cognitive Impairment
Darren Haywood, Moira O’Connor, Frank D. Baughman, et al.
Methods and Protocols (2024) Vol. 7, Iss. 4, pp. 54-54
Open Access | Times Cited: 5
Long-Term Cognitive Outcomes in Adult Patients Receiving Chimeric Antigen Receptor T-Cell Therapies
Anna Barata, P. Connor Johnson, Tejaswini Dhawale, et al.
Transplantation and Cellular Therapy (2025)
Closed Access
Accounting for unmet needs resulting from cancer-related cognitive impairment
Darren Haywood, Alexandre Chan, Raymond J. Chan, et al.
Journal of Cancer Survivorship (2025)
Open Access
Self- and informant-reported cognitive concerns associated with primary brain tumour: systematic review
Shelley Mekler, Sian Virtue-Griffiths, Kerryn E. Pike
Supportive Care in Cancer (2025) Vol. 33, Iss. 4
Open Access
Cancer-related cognitive impairment in patients with hematologic malignancies after CAR T cell therapy: a systematic review and meta-analysis of prevalence
Mu‐Hsing Ho, Denise Shuk Ting Cheung, Tongyao Wang, et al.
Supportive Care in Cancer (2025) Vol. 33, Iss. 4
Open Access
Development of a rapid screener through network analysis to identify central cognitive complaints in haemodialysis patients: a cross-sectional study
Frederick H. F. Chan, Pearl Sim, Phoebe X. H. Lim, et al.
BMJ Open (2025) Vol. 15, Iss. 3, pp. e088502-e088502
Open Access
Pilot randomized study of adaptive cognitive training’s effect on breast cancer survivors assessed through eye tracking
Yuxin Huang, Ze Yu, Youyang Wang, et al.
Journal of Cancer Survivorship (2025)
Open Access
Screening for cognitive symptoms among cancer patients during chemotherapy: Sensitivity and specificity of a single item self‐report cognitive change score
Joanna E. Fardell, Victoria Bray, Melanie L. Bell, et al.
Psycho-Oncology (2022) Vol. 31, Iss. 8, pp. 1294-1301
Open Access | Times Cited: 19
Validating the PROMIS cognitive function short form in cancer survivors
Ashley M. Henneghan, Kathleen Van Dyk, Xingtao Zhou, et al.
Breast Cancer Research and Treatment (2023) Vol. 201, Iss. 1, pp. 139-145
Open Access | Times Cited: 11
The prevalence of mild cognitive impairment in breast cancer patients receiving chemotherapy according to the criteria of the National Institute on Aging-Alzheimer’s Association (NIA-AA)
Elaine A. C. Albers, Jacobien M. Kieffer, Sanne B. Schagen
Journal of Cancer Survivorship (2024)
Open Access | Times Cited: 4
Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: A scoping review
Kate Oppegaard, Terri S. Armstrong, Joaquin A. Anguera, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 180, pp. 103822-103822
Open Access | Times Cited: 17
Age-related decline in hippocampal tyrosine phosphatase PTPRO is a mechanistic factor in chemotherapy-related cognitive impairment
Zhimeng Yao, Hongmei Dong, Jianlin Zhu, et al.
JCI Insight (2023) Vol. 8, Iss. 14
Open Access | Times Cited: 10
Young Adults’ Lived Experiences with Cancer-Related Cognitive Impairment: An Exploratory Qualitative Study
Sitara Sharma, Jennifer Brunet
Current Oncology (2023) Vol. 30, Iss. 6, pp. 5593-5614
Open Access | Times Cited: 9
Improve the management of cancer-related cognitive impairment in clinical settings: a European Delphi study
Mylène Duivon, Marie Lange, Giulia Binarelli, et al.
Journal of Cancer Survivorship (2023) Vol. 18, Iss. 6, pp. 1974-1997
Open Access | Times Cited: 8
Blood and neuroimaging biomarkers of cognitive sequelae in breast cancer patients throughout chemotherapy: A systematic review
Gwen Schroyen, Julie Vissers, Ann Smeets, et al.
Translational Oncology (2021) Vol. 16, pp. 101297-101297
Open Access | Times Cited: 19
Subjective cognition and memory lapses in the daily lives of breast cancer survivors: Examining associations with objective cognitive performance, fatigue, and depressed mood
Britney Veal, Stacey Scott, Heather Jim, et al.
Psycho-Oncology (2023) Vol. 32, Iss. 8, pp. 1298-1305
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top